The Ministry of Industry has resolved the 2022 call for the 'Profarma (2021-2022) program: Promotion of competitiveness in the Pharmaceutical Industry'. In this call, 49 pharmaceutical companies have been evaluated. Of them, nine have been rated as 'Excellent', ten as 'Very Good', five as 'Good', and seventeen as 'Acceptable'. Several of them are associated with BioSim.